26.13
Pacira Biosciences Inc (PCRX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
7.21%
181.10
|
168.92 | 168.57 | 178.02 | 167.12 |
Cost Of Revenue |
19.12%
40.87
|
34.31 | 38.86 | 44.26 | 47.42 |
Gross Profit |
4.17%
140.23
|
134.62 | 129.71 | 133.76 | 119.70 |
|
0.67%
131.73
|
132.63 | 269.24 | 105.52 | 106.49 |
Benefits Costs and Expenses |
14.24%
183.03
|
160.22 | 307.43 | 141.44 | 153.48 |
Costs And Expenses |
3.39%
172.60
|
166.93 | 308.10 | 149.78 | 153.91 |
Operating Income/Loss |
327.09%
8.499
|
1.99 | -139.53 | 28.24 | 13.21 |
Nonoperating Income/Loss |
255.24%
-10.43
|
6.716 | 0.671 | 8.344 | 0.428 |
Income/Loss From Continuing Operations Before Tax |
122.13%
-1.927
|
8.706 | -138.86 | 36.58 | 13.64 |
Income Tax Expense/Benefit, Deferred |
46.17%
0.752
|
1.397 | 1.115 | 12.54 | 3.463 |
Income Tax Expense/Benefit |
25.01%
2.92
|
3.894 | 4.61 | 17.70 | 4.661 |
Income/Loss From Continuing Operations After Tax |
200.73%
-4.847
|
4.812 | -143.47 | 18.89 | 8.979 |
|
200.73%
-4.847
|
4.812 | -143.47 | 18.89 | 8.979 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.76%
45.46
|
46.27 | 46.13 | 46.17 | 46.50 |
Diluted Average Shares |
2.29%
45.46
|
46.53 | 46.13 | 50.54 | 52.19 |
Basic Earnings Per Share |
210.00%
-0.11
|
0.10 | -3.11 | 0.41 | 0.19 |
Diluted Earnings Per Share |
210.00%
-0.11
|
0.10 | -3.11 | 0.39 | 0.19 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):